These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4868478)

  • 21. Possible mechanism of aggregation of blood platelets by adenosine diphosphate.
    Salzman EW; Chambers DA; Neri LL
    Nature; 1966 Apr; 210(5032):167-9. PubMed ID: 5962074
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostaglandins and platelet aggregation in vivo. I. Influence of PGE1 and omega-homo-PGE1 on transient thrombocytopenia and of PGE1 on the LD50 of ADP.
    Kloeze J
    Thromb Diath Haemorrh; 1970 May; 23(2):286-92. PubMed ID: 5426210
    [No Abstract]   [Full Text] [Related]  

  • 23. [Aggregation capacity of the platelets of various animal species. (Microscopic and photometric study)].
    Sinakos Z; Caen J
    Nouv Rev Fr Hematol; 1967; 7(1):120-4. PubMed ID: 4226628
    [No Abstract]   [Full Text] [Related]  

  • 24. Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds, and adenosine.
    Skoza L; Zucker MB; Jerushalmy Z; Grant R
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):713-25. PubMed ID: 4952980
    [No Abstract]   [Full Text] [Related]  

  • 25. On the role of vasoactive substances in haemodynamic changes induced by thrombin.
    Swedenborg J
    Acta Chir Scand; 1971; ():1-20. PubMed ID: 5556381
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of inhibitors of aggregation on platelet ultrastructure in vitro.
    Mannucci PM; Sirigu F
    Thromb Diath Haemorrh; 1969 Apr; 21(2):354-61. PubMed ID: 5769056
    [No Abstract]   [Full Text] [Related]  

  • 27. Some effects of trypsin and streptokinase on platelet aggregation.
    Wilson PA; McNicol GP; Douglas AS
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):66-75. PubMed ID: 6066606
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on plasma factor involved in 5-hydroxy-tryptamine release from blood platelets by bacterial endotoxin. I. Presence of 5-hydroxytryptamine releasing factor in rabbit plasma and its interaction with heparin and endotoxin.
    Nomura Y; Takagi H
    Jpn J Pharmacol; 1972 Feb; 22(1):37-42. PubMed ID: 4537623
    [No Abstract]   [Full Text] [Related]  

  • 29. [The blood platelets in thrombogenesis. The mechanism and inhibition of the aggregation of blood platelets].
    Born GV
    Actual Pharmacol (Paris); 1965; 18():17-32. PubMed ID: 5874959
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction of platelet adhesiveness by adenosine diphosphate and triphosphate.
    Busfield D; Tomich EG
    Nature; 1967 Jun; 214(5095):1360-1. PubMed ID: 6056857
    [No Abstract]   [Full Text] [Related]  

  • 31. The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction.
    O'Brien JR; Heywood JB; Heady JA
    Thromb Diath Haemorrh; 1966 Dec; 16(3):752-67. PubMed ID: 5998919
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelet pharmacology in relation to thrombosis.
    Born GV
    Adv Cardiol; 1970; 4():161-74. PubMed ID: 4924078
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenine nucleotide metabolism of blood platelets. II. Uptake of adenosine and inhibition of ADP-induced platelet aggregation.
    Rozenberg MC; Holmsen H
    Biochim Biophys Acta; 1968 Feb; 155(2):342-52. PubMed ID: 5637063
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet-endotoxin interaction: a review.
    Semeraro N; Fumarola D; Telesforo P; Vermylen J
    Boll Ist Sieroter Milan; 1976; 55(6):577-86. PubMed ID: 798597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 5-hydroxytryptamine on platelet aggregation.
    Baumgartner HR; Born GV
    Nature; 1968 Apr; 218(5137):137-41. PubMed ID: 5645287
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on plasma factor involved in 5-hydroxytryptamine release from blood platelets by bacterial endotoxin. 3. Mechanism of action of 5-hydroxytryptamine releasing factor.
    Nomura Y; Okada T; Takagi H
    Jpn J Pharmacol; 1972 Feb; 22(1):79-87. PubMed ID: 4537627
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of in vivo injury-induced platelet thrombosis by inhibitors of adenosine diphosphate thrombotic activity.
    Berman HJ
    Bibl Anat; 1967; 9():92-7. PubMed ID: 6029912
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of ADP-induced thrombocyte aggregation by adenosine and adenosine derivatives. 1. Quantification of antagonism between ADP and adenosine in vitro].
    Birkenheier H; Dietmann K; Schaumann W
    Arzneimittelforschung; 1970 Oct; 20(10):1569-71. PubMed ID: 5536426
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombocytopenia and release of platelet amines induced by thrombin and bacterial lipopolysaccharide. Observations after infusion of low molecular weight dextran.
    Davis RB; Palmer MJ
    Br J Exp Pathol; 1965 Oct; 46(5):554-63. PubMed ID: 5838404
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of nicotine and inactivity of kallikrein and kallidin in aggregation of blood platelets.
    Werle E; Schievelbein H
    Nature; 1965 Aug; 207(999):871-2. PubMed ID: 5885953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.